NewEast/Cdc42蛋白[10107][100µg]/10107

价格
¥4780.00
货号:10107
浏览量:101
品牌:NewEastBio
服务
全国联保
正品保证
正规发票
签订合同
商品描述

CatalogNumber:  10107
ProductName:  Cdc42Protein
Synonyms:  Celldivisioncycle42,G25K,CDC42Hs
Source:  Human,recombinantfulllength,His6-tag
ExpressionHost:  E.coli
MolecularWeight:  21kDa
Purity:  >95%bySDS-PAGE
Introduction:  SmallGTPasesareasuper-familyofcellularsignalingregulators.Cdc42belongstotheRhosub-familyofGTPasesthatregulatecellmotility,celldivision,andgenetranscription.GTPbindingincreasestheactivityofCdc42,andthehydrolysisofGTPtoGDPrendersitinactive.GTPhydrolysisisaidedbyGTPaseactivatingproteins(GAPs),whileexchangeofGDPforGTPisfacilitatedbyguaninenucleotideexchangefactors(GEFs).
AminoAcidSequence  (1-191)
MQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPTVFDNYAVTVMIGGEPYTLGLFDTAGQEDYDRL RPLSYPQTDVFLVCFSVVSPSSFENVKEKWVPEITHHCPKTPFLLVGTQIDLRDDPSTIEKLAKNKQ KPITPETAEKLARDLKAVKYVECSALTQKGLKNVFDEAILAALEPPEPKKSRRCVLL
Properties
PhysicalAppearance(form):  Dissolvedin20mMTris-HCl,pH8.0,150mMNaCl.
PhysicalAppearance(form):  Whiteorclear
Concentration:  1mg/mL
Storage:  -80°C
PreparationInstructions:  Centrifugethevialbeforeopenthecapandreconstituteinwater.Addingof10mMβ-mercaptoethanolor1mMDTTintothesolutiontoprotecttheproteinisrecommendedandusingofnon-ionicdetergentssuchasn-Dodecylβ-D-maltoside(DoDM)orpolyethylenedetergents(e.g.C12E10)alsohelptostABIlizetheprotein.Avoidrepeatedfreezingandthawingafterreconstitution.ThepurityofHis-taggedCdc42wasdeterminedbySDS-PAGEandCoomassieBrilliantBlueStaining.
References:  1.Garrett,W.S..etal.,Cell102:325-334,2000.2.Irie,F.etal.,NatureNeurosci.5:1117-1118,2002.3.Kawasaki,Y.etal.,Oncogene26:7620-7627,2007.4.Manser,E.etal.,Nature363:364-367,1993.5.Musch,A.etal.,EMBOJ.20:2171-2179,2001.6.Nalbant,P.etal.,Science305:1615-1619,2004.7.Shen,Y.etal.,Dev.Cell14:342-353,2008.8.Wu,W.J.etal.,Nature405:800-804,2000.9.Wu,X.etal.,GenesDev.20:571-585,2006.10.Zheng,Y.etal.,J.Biol.Chem.271:33169-33172,1996.
Datasheet:  
定制肽合成NewEast Biosciences为全球生物研究界提供高质量的粗制和纯化肽或拟肽。我们使用先进的自动,半自动和手动合成器以及Fmoc技术合成肽。肽酰胺键通过HOAT / HATU偶联形成。我们的肽通过制备型HPLC纯化,并且每个级分均通过使用不同溶剂系统的分析型HPLC进行进一步分析。收集并冻干仅通过质谱法验证的具有单个峰的级分。肽通常在1-2周内递送。粗肽也可以大量节省(参见价格表)。周转时间为5-7天。除了正常的肽合成外,我们还合成修饰的肽和多种抗原性肽(MAPs)。修饰在C末端,N末端和内部残基处进行。在C末端,氨基可与羧酸,异氰酸酯和磺酰氯反应形成酰胺,脲和磺酰胺。在此终端进行经典的生物素化,荧光标记和脂质化。这些修饰以及磷酸化和糖基化也可以在内部残基处进行。相反,在C末端的修饰非常具有挑战性,需要溶液阶段的干预。为了在C端进行修饰,必须将肽从树脂中释放出来。然后,用相应的化学方法修饰释放的肽。但是,我们已经开发了适当的化学方法,可以在固相的C末端引入生物素,荧光染料和胺。随着化学,我们降低了合成肽以及昂贵试剂的成本。作为NewEast的客户,我们将节省下来的钱转嫁给您。
  • 资质认证

    获得国家资质,权威认证!

  • 全国联保

    全国联保,官方无忧售后

  • 正规发票

    正规发票,放心购买

  • 签订合同

    签订合同,保障您的权益

/**/
Publications:
1.  VibrioparahaemolyticusEffectorProteinsSuppressInflammasomeActivationbyInterferingwithHostAutophagySignaling    PLoSPathog.2013Jan;9(1):e1003142
2.  Interferongammainducesactinpolymerization,Rac1activationanddownregulatesphagocytosisinhumanmonocyticcells    Cytokine.2012Jan;57(1):158-68
3.  Invadopodiaandrolling-typemotilityarespecificfeaturesofhighlyinvasivep190bcr-ablleukemiccells    EuropeanJournalofCellBIOLOGyVolume91,Issues11–12,November–December2012,Pages978–987
4.  EpithelialjunctionformationrequiresconfinementofCdc42activitybyanovelSH3BP1complex    JCellBiol.2012Aug20;198(4):677-93
5.  PolarizedmigrationoflymphaticendothelialcellsiscriticallydependentonpodoplaninregulationofCdc42    AmJPhysiolLungCellMolPhysiol.2011Jan;300(1):L32-42
6.  TheAarskog-ScottSyndromeProteinFgd1RegulatesPodosomeFormationandExtracellularMatrixRemodelinginTransformingGrowthFactorbeta-StimulatedAorticEndothelialCells    MolCellBiol.2011Nov;31(22):4430-41
7.  MMP-9andCXCL8/IL-8ArePotentialTherapeuticTargetsinEpidermolysisBullosaSimplex    PLoSOne.2013Jul19;8(7):e70123
8.  p21-ActivatedKinase(PAK)RegulatesCytoskeletalReorganizationandDirectionalMigrationinHumanNeutrophils    PLoSOne.2013Sep3;8(9):e73063
9.  TheCdc42GuanineNucleotideExchangeFactorFGD6CoordinatesCellPolarityandEndosomalMembraneRecyclinginOsteoclasts    JBiolChem.2014Jun27;289(26):18347-59
10.  Cdc42InhibitorandUsesThereof    UnitedStatesPatentApplication20140194451
11.  Theα4NicotinicReceptorPromotesCD4+T-CellProliferationandaHelperT-CellImmuneResponse    MolecularPharmacologyJanuary2014vol.85no.150-61